Delivery Order SPE2DB22D1106-SPE2DB24FFLM8
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,538.05 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a diabetes medication, with a period of performance through March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $4,736.67 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Bydureon BCISE 2 mg Autoinjector 0.85 mL. The contract has an ultimate completion date of August 29, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,908.86 firm fixed-price contract is for the supply of Bydureon Bcise 2 mg autoinjectors, a medication used to treat type 2 diabetes. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $1,046.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the medication Bydureon BCISE 2 mg autoinjector 0.85 mL. The award has an ultimate completion date of February 22, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management, holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a $5,260.74 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,942.86, is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bydureon Bcise 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has a ceiling value of $7,900.38 and a completion date of March 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $21,786.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Bydureon BCISE 2 mg autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,456.15, is for the supply of Bydureon BCISE 2 mg autoinjector syringes, a medication used for the treatment of type 2 diabetes. The contract has a firm fixed price pricing structure and an ultimate completion date of December 31, 2024. This contract is not designated as a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,390.34 firm-fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...